2022
DOI: 10.1016/j.celrep.2022.111571
|View full text |Cite
|
Sign up to set email alerts
|

Nuclear stabilization of p53 requires a functional nucleolar surveillance pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
33
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 27 publications
(37 citation statements)
references
References 69 publications
4
33
0
Order By: Relevance
“…2B). These results agree with a genome-wide RNAi screen in A549 cells to identify proteins whose depletion leads to TP53 stabilization, where APOBEC3A was a top hit (Data S1) (19). Taken together, these results indicate that acute depletion of APOBEC3A induces the nucleolar stress response which leads to inhibition of cell cycle progression and to reduced cell viability.…”
Section: Resultssupporting
confidence: 88%
See 3 more Smart Citations
“…2B). These results agree with a genome-wide RNAi screen in A549 cells to identify proteins whose depletion leads to TP53 stabilization, where APOBEC3A was a top hit (Data S1) (19). Taken together, these results indicate that acute depletion of APOBEC3A induces the nucleolar stress response which leads to inhibition of cell cycle progression and to reduced cell viability.…”
Section: Resultssupporting
confidence: 88%
“…No reuse allowed without permission. To connect APOBEC3A's potential role in ribosome biogenesis with the cell cycle, we tested for the induction of the nucleolar stress response (17)(18)(19) after APOBEC3A siRNA depletion. The nucleolar stress response results in a change in nucleolar morphology, increased levels of TP53 and its transcriptional target CDKN1A (62), and ultimately cell cycle arrest and apoptosis.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…As patients with congenital ribosomopathies age, they are at a 2.5- to 8.5-fold increased risk for developing cancer [ 114 ]. In many cancer cells, the heterozygous deletion of an RP gene is often accompanied by a TP53 mutation [ 117 ]. These somatic mutations in RPs include uL18/RPL5, uL16/RPL10, uL5/RPL11, eL22/RPL22, and uL23/RPL23A.…”
Section: Disease-associated Ribosomal Heterogeneity and Specializationmentioning
confidence: 99%